DK1441726T3 - Derivater af phenoxy-N' -4-(isothiazolidin-1,1-dioxid-2-yl)phenyl]-valerianesyreamid og andre forbindelser som inhibitorer af koagulationsfaktoren Xa til behandling af thromboemboliske lidelser og tumorer - Google Patents
Derivater af phenoxy-N' -4-(isothiazolidin-1,1-dioxid-2-yl)phenyl]-valerianesyreamid og andre forbindelser som inhibitorer af koagulationsfaktoren Xa til behandling af thromboemboliske lidelser og tumorerInfo
- Publication number
- DK1441726T3 DK1441726T3 DK02802623T DK02802623T DK1441726T3 DK 1441726 T3 DK1441726 T3 DK 1441726T3 DK 02802623 T DK02802623 T DK 02802623T DK 02802623 T DK02802623 T DK 02802623T DK 1441726 T3 DK1441726 T3 DK 1441726T3
- Authority
- DK
- Denmark
- Prior art keywords
- isothiazolidin
- phenoxy
- tumors
- inhibitors
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10155075A DE10155075A1 (de) | 2001-11-09 | 2001-11-09 | Cyclische Sulfonamide |
| PCT/EP2002/011349 WO2003039543A1 (de) | 2001-11-09 | 2002-10-10 | Derivate des phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian-säureamids und andere verbindungen als inhibitoren des koagulationsfaktors xa zur behandlung von thromboembolischen erkrankungen und tumoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1441726T3 true DK1441726T3 (da) | 2007-04-10 |
Family
ID=7705183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02802623T DK1441726T3 (da) | 2001-11-09 | 2002-10-10 | Derivater af phenoxy-N' -4-(isothiazolidin-1,1-dioxid-2-yl)phenyl]-valerianesyreamid og andre forbindelser som inhibitorer af koagulationsfaktoren Xa til behandling af thromboemboliske lidelser og tumorer |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7199133B2 (ru) |
| EP (1) | EP1441726B1 (ru) |
| JP (1) | JP4447909B2 (ru) |
| KR (1) | KR20050035165A (ru) |
| CN (1) | CN1582148A (ru) |
| AR (1) | AR037342A1 (ru) |
| AT (1) | ATE348611T1 (ru) |
| AU (1) | AU2002363366B2 (ru) |
| BR (1) | BR0213680A (ru) |
| CA (1) | CA2465713A1 (ru) |
| DE (2) | DE10155075A1 (ru) |
| DK (1) | DK1441726T3 (ru) |
| ES (1) | ES2277623T3 (ru) |
| HU (1) | HUP0401983A2 (ru) |
| MX (1) | MXPA04004307A (ru) |
| MY (1) | MY134079A (ru) |
| PL (1) | PL369737A1 (ru) |
| PT (1) | PT1441726E (ru) |
| RU (1) | RU2301228C2 (ru) |
| WO (1) | WO2003039543A1 (ru) |
| ZA (1) | ZA200404549B (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2416384A1 (en) * | 2000-07-17 | 2003-01-16 | Takeda Chemical Industries, Ltd. | Sulfone derivatives, their production and use |
| US20040152741A1 (en) * | 2002-09-09 | 2004-08-05 | Nps Allelix Corporation | Arylglycine derivatives and their use as glycine transport inhibitors |
| WO2004048363A1 (ja) * | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | イミダゾール誘導体、その製造法および用途 |
| US7371743B2 (en) * | 2004-02-28 | 2008-05-13 | Boehringer Ingelheim International Gmbh | Carboxylic acid amides, the preparation thereof and their use as medicaments |
| TWI396686B (zh) * | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| DE102004054847A1 (de) * | 2004-11-13 | 2006-05-24 | Sanofi-Aventis Deutschland Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| KR101009594B1 (ko) * | 2007-05-09 | 2011-01-20 | 주식회사 레고켐 바이오사이언스 | Ｐ4 위치에 사이클릭 아미딘을 가지는 ＦＸａ 저해제, 이의유도체, 제조방법 및 이를 함유하는 의약 조성물 |
| PT2915564T (pt) * | 2007-09-28 | 2021-02-09 | Alexion Pharma Inc | Antídotos para inibidores do fator xa e métodos de utilização dos mesmos |
| RU2015121347A (ru) | 2012-11-05 | 2016-12-27 | НЭНТ ХОЛДИНГЗ АйПИ, ЭлЭлСи | Производные, содержащие циклическую сульфонамидную группу, в качестве ингибиторов сигнального пути hedgenog |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300523A (en) | 1988-07-28 | 1994-04-05 | Bayer Aktiengesellschaft | Substituted aminomethyltetralins and their heterocyclic analogues |
| DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| DE69331103T2 (de) * | 1992-08-19 | 2002-03-14 | Pfizer | Substituierte benzylamin-stickstoff enthaltende nichtaromatische heterocyclen |
| US5550139A (en) | 1994-01-03 | 1996-08-27 | The Wichita State University | Serine protease inhibitors |
| GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| US6489300B1 (en) | 1997-07-31 | 2002-12-03 | Eugene D. Thorsett | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| AR016133A1 (es) * | 1997-07-31 | 2001-06-20 | Wyeth Corp | Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria |
| DE19751949A1 (de) | 1997-11-24 | 1999-05-27 | Bayer Ag | Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration |
| DE19754573A1 (de) * | 1997-12-09 | 1999-06-10 | Bayer Ag | Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma |
| US6114532A (en) | 1998-02-03 | 2000-09-05 | Boehringer Ingelheim Pharma Kg | Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals |
| DE19804085A1 (de) | 1998-02-03 | 1999-08-05 | Boehringer Ingelheim Pharma | 5-Gliedrige heterocyclische kondensierte Benzoderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| ES2219319T3 (es) * | 1999-03-17 | 2004-12-01 | Astrazeneca Ab | Derivados de amida. |
| KR20020070385A (ko) * | 2000-01-29 | 2002-09-06 | 주식회사 엘지씨아이 | 아릴-아미딘을 가진 팩터 Ｘａ 억제제와 그의 유도체, 및그의 프로드럭 |
| KR100423899B1 (ko) * | 2000-05-10 | 2004-03-24 | 주식회사 엘지생명과학 | 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸 |
| CZ20031028A3 (cs) | 2000-10-12 | 2003-08-13 | Merck & Co., Inc. | Aza- a polyazanaftalenylkarboxamidy |
| US6488154B1 (en) * | 2000-10-16 | 2002-12-03 | Ming-Chuan Yeh | Chip tray |
-
2001
- 2001-11-09 DE DE10155075A patent/DE10155075A1/de not_active Withdrawn
-
2002
- 2002-10-10 PT PT02802623T patent/PT1441726E/pt unknown
- 2002-10-10 KR KR1020047005508A patent/KR20050035165A/ko not_active Application Discontinuation
- 2002-10-10 ES ES02802623T patent/ES2277623T3/es not_active Expired - Lifetime
- 2002-10-10 DE DE50209031T patent/DE50209031D1/de not_active Expired - Lifetime
- 2002-10-10 DK DK02802623T patent/DK1441726T3/da active
- 2002-10-10 US US10/495,254 patent/US7199133B2/en not_active Expired - Fee Related
- 2002-10-10 PL PL02369737A patent/PL369737A1/xx unknown
- 2002-10-10 BR BR0213680-5A patent/BR0213680A/pt not_active IP Right Cessation
- 2002-10-10 HU HU0401983A patent/HUP0401983A2/hu unknown
- 2002-10-10 CA CA002465713A patent/CA2465713A1/en not_active Abandoned
- 2002-10-10 RU RU2004117594/04A patent/RU2301228C2/ru not_active IP Right Cessation
- 2002-10-10 EP EP02802623A patent/EP1441726B1/de not_active Expired - Lifetime
- 2002-10-10 CN CNA028219198A patent/CN1582148A/zh active Pending
- 2002-10-10 WO PCT/EP2002/011349 patent/WO2003039543A1/de active IP Right Grant
- 2002-10-10 AU AU2002363366A patent/AU2002363366B2/en not_active Ceased
- 2002-10-10 JP JP2003541834A patent/JP4447909B2/ja not_active Expired - Fee Related
- 2002-10-10 AT AT02802623T patent/ATE348611T1/de not_active IP Right Cessation
- 2002-10-10 MX MXPA04004307A patent/MXPA04004307A/es unknown
- 2002-11-06 MY MYPI20024148A patent/MY134079A/en unknown
- 2002-11-08 AR ARP020104288A patent/AR037342A1/es unknown
-
2004
- 2004-06-08 ZA ZA200404549A patent/ZA200404549B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04004307A (es) | 2004-08-11 |
| RU2301228C2 (ru) | 2007-06-20 |
| JP2005522412A (ja) | 2005-07-28 |
| AR037342A1 (es) | 2004-11-03 |
| DE10155075A1 (de) | 2003-05-22 |
| HUP0401983A2 (hu) | 2005-01-28 |
| BR0213680A (pt) | 2004-10-26 |
| ES2277623T3 (es) | 2007-07-16 |
| CA2465713A1 (en) | 2003-05-15 |
| JP4447909B2 (ja) | 2010-04-07 |
| US20040254175A1 (en) | 2004-12-16 |
| ATE348611T1 (de) | 2007-01-15 |
| EP1441726B1 (de) | 2006-12-20 |
| EP1441726A1 (de) | 2004-08-04 |
| WO2003039543A1 (de) | 2003-05-15 |
| PT1441726E (pt) | 2007-03-30 |
| CN1582148A (zh) | 2005-02-16 |
| US7199133B2 (en) | 2007-04-03 |
| KR20050035165A (ko) | 2005-04-15 |
| ZA200404549B (en) | 2005-02-04 |
| MY134079A (en) | 2007-11-30 |
| PL369737A1 (en) | 2005-05-02 |
| RU2004117594A (ru) | 2006-01-10 |
| DE50209031D1 (de) | 2007-02-01 |
| AU2002363366B2 (en) | 2007-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE359271T1 (de) | Phenylderivate | |
| DE60330895D1 (de) | Verbindungen, die sich als inhibitoren vonjak und anderen proteinkinasen eignen | |
| DK1423381T3 (da) | 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme | |
| ATE371656T1 (de) | Heteroaryl-pyrimidinderivate als jak-inhibitoren | |
| MXPA04001889A (es) | Inhibidores de la alquin-aril fosfodiesterasa-4. | |
| IS7840A (is) | 3-(3,5-díoxó-4,5-díhýdró-3H-(1,2,4)tríasín-2-ýl)-bensamíð afleiður sem P2X7-hindrar til notkunar í meðferð á bólguvaldandi sjúkdómum | |
| NO20053470L (no) | Triazolopyridaziner som proteinkinase-inhibitorer | |
| NO20054787L (no) | Indenderivater som farmasotiske midler | |
| JP2007506758A5 (ja) | ４−（１−ベンゾフラン−３−イル−メチリデンアミノオキシ−プロポキシ）−安息香酸誘導体および線溶系の障害、血栓症の治療用のｐａｉ−１阻害剤としての関連化合物 | |
| MXPA03009750A (es) | Compuestos quimicos. | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| EA200301276A1 (ru) | Новые производные сульфоновых кислот | |
| DK1279665T3 (da) | Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser | |
| WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
| WO2004002477A8 (de) | 2-(phenyl)-2h-pyrazol-3-carbonsäure-n-4-(thioxo-heterocyclyl)-phenyl-amid derivate und entsprechende imino-heterocyclyl derivate sowie verwandte verbindungen als inhibitoren der koagulationsfaktoren xa und/oder viia zur behandlung bon thrombosen | |
| DK1441726T3 (da) | Derivater af phenoxy-N' -4-(isothiazolidin-1,1-dioxid-2-yl)phenyl]-valerianesyreamid og andre forbindelser som inhibitorer af koagulationsfaktoren Xa til behandling af thromboemboliske lidelser og tumorer | |
| NO20052994L (no) | Nye fosforamidderivater. | |
| WO2004041802A8 (en) | 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders | |
| SE0302756D0 (sv) | Novel Compounds | |
| NO20050885D0 (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| DE50205466D1 (de) | Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen | |
| MXPA03010205A (es) | Derivados de acido oxalico. | |
| DK1434588T3 (da) | 2-(amino-3,4-dioxo-1cyclobuten-1-yl)aminoalkylsyrederivater til behandling af smerte | |
| DK1309322T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser | |
| AU2002363366A1 (en) | Derivatives of phenoxy-N- 4-(isothiazolidin-1,1-dioxid-2YL)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor XA in the treatment of thromboembolic diseases and tumors |